232 related articles for article (PubMed ID: 36380646)
1. Active screening of COVID-19-associated pulmonary aspergillosis with serum beta-glucan and endotracheal aspirates galactomannan and fungal culture.
Pavone P; Russello G; Salati G; Corsini R; Salsi P; Vizzini L; Lombardini C; Spaggiari L; Besutti G; Menozzi V; Spadoni A; Facciolongo N; Piro R; Carretto E; Massari M
Mycoses; 2023 Mar; 66(3):219-225. PubMed ID: 36380646
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
[TBL] [Abstract][Full Text] [Related]
8. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
[TBL] [Abstract][Full Text] [Related]
9. Tendency in Pulmonary Aspergillosis Investigation during the COVID-19 Era: What Is Changing?
Caggiano G; Apollonio F; Consiglio M; Gasparre V; Trerotoli P; Diella G; Lopuzzo M; Triggiano F; Stolfa S; Mosca A; Montagna MT
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742328
[TBL] [Abstract][Full Text] [Related]
10. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
11. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.
Roman-Montes CM; Martinez-Gamboa A; Diaz-Lomelí P; Cervantes-Sanchez A; Rangel-Cordero A; Sifuentes-Osornio J; Ponce-de-Leon A; Gonzalez-Lara MF
Mycoses; 2021 Apr; 64(4):364-371. PubMed ID: 33217784
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
Çuhadar T; Kalkancı A; Tunçcan Güzel Ö; Yeğin ZA; Özkurt ZN; Köktürk N; Yağcı M
Mikrobiyol Bul; 2023 Apr; 57(2):274-282. PubMed ID: 37067211
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
[TBL] [Abstract][Full Text] [Related]
15. Performance of galactomannan testing from endotracheal aspirate to guide bronchoalveolar lavage in the diagnosis of invasive aspergillosis.
Dichtl K; Barry R; Angstwurm MWA; Suerbaum S; Wagener J
Infection; 2023 Jun; 51(3):769-774. PubMed ID: 36738420
[TBL] [Abstract][Full Text] [Related]
16. Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?
Dellière S; Dudoignon E; Voicu S; Collet M; Fodil S; Plaud B; Chousterman B; Bretagne S; Azoulay E; Mebazaa A; Dépret F; Mégarbane B; Alanio A
J Clin Microbiol; 2022 Mar; 60(3):e0216921. PubMed ID: 34985983
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
[TBL] [Abstract][Full Text] [Related]
18. [The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Sav H; Atalay MA; Unal E; Koç N
Mikrobiyol Bul; 2012 Oct; 46(4):695-701. PubMed ID: 23188584
[TBL] [Abstract][Full Text] [Related]
19. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of
Takazono T; Ito Y; Tashiro M; Nishimura K; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]